Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.
OBJECTIVES: The use of clinical staging in the fatal neurodegenerative disease amyotrophic lateral sclerosis would have value in optimising future therapeutic trials. We aimed to use previous clinical trial data to determine the length of time patients spend in each of four proposed stages, its rang...
Main Authors: | Balendra, R, Jones, A, Jivraj, N, Steen, I, Young, C, Shaw, P, Turner, M, Leigh, P, Al-Chalabi, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2015
|
Títulos similares
-
Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
por: Balendra, R, et al.
Publicado: (2015) -
Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
por: Jones, A, et al.
Publicado: (2014) -
Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.
por: Balendra, R, et al.
Publicado: (2014) -
Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data
por: Jones, A, et al.
Publicado: (2013) -
Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System
por: Balendra, R, et al.
Publicado: (2013)